发明名称 Pharmacologically active chromanes
摘要 Racemic Compounds of the formula <IMAGE> I A is -C 3BOND C-R6, -CH2-CH2-R7 or <IMAGE> R1 is hydrogen or lower alkanoyl, R2, R3, and R4 independently are hydrogen or lower alkyl, R5 is lower alkyl, R6 is a heteroaromatic radical or an aromatic radical selected from phenyl, naphthyl or phenanthryl, which aromatic radical may optionally be substituted by one or more substituents selected from chlorine, fluorine, lower alkyl, lower alkoxy, phenyl lower alkoxy, lower alkanoyl, lower alkanoyloxy, hydroxy-lower alkyl, carboxy, lower alkoxycarbonyl, hydroxyimino lower alkyl, amino, amino lower alkyl, mono- or di-lower alkylamino, mono- or di-lower alkylamino-lower alkyl, lower alkanoylamino, aminocarbonyl, lower alkylaminocarbonyl, lower dialkylaminocarbonyl, trifluoroacetylamino, trifluoromethyl, hydroxy, pyridyl, or on adjacent carbons can be <IMAGE> wherein R' is hydrogen, lower alkanoyl, trifluoroacetyl and R'' hydrogen or lower alkyl, R7 is a heteroaromatic radical or an aromatic radical selected from phenyl, naphthyl or phenanthryl, which aromatic radical may optionally be substituted by one or more substituents selected from chlorine, fluorine, lower alkyl, lower alkoxy, phenyl-lower alkoxy of 2-7 carbon atoms, lower alkanoyl, lower alkanoyloxy, hydroxy-lower alkyl, carboxy, lower alkoxycarbonyl, amino, amino-lower alkyl, mono- or di-lower alkylamino, mono- or di-lower alkylamino-lower alkyl, lower alkanoylamino, aminocarbonyl, lower alkylaminocarbonyl, lower dialkylaminocarbonyl, trifluoroacetylamino, trifluoromethyl, hydroxy or pyridyl, or on adjacent carbons can be <IMAGE> wherein R' is hydrogen, lower alkanoyl, trifluoroacetyl and R'' hydrogen or lower alkyl, R8, R9, and R10, independently, are hydrogen, hydroxy, lower alkyl, lower alkoxy, hydroxy lower alkyl, fluorine, chlorine or lower alkanoyl provided that no more than one of R8, R9, and R10 is hydroxy, lower alkoxy, lower hydroxyalkyl, fluorine, chlorine or lower alkanoyl, and Y is CH or N, and their enantiomer and salts thereof are described. The compounds of formula I exhibit activity as inhibitors of 5-lipoxygenase and inhibit lipid peroxidation. They are, therefore, useful in the treatment of diseases caused or aggravated by excess oxidative metabolism of arachidonic acid via the 5-lipoxygenase pathway and in the treatment of inflammation, arthritis, allergies, asthma and psoriasis. The compounds of formula I can also be used to prevent peroxidation of lipids and thus protect lipid membranes from oxidative stress.
申请公布号 US5132310(A) 申请公布日期 1992.07.21
申请号 US19900627523 申请日期 1990.12.14
申请人 HOFFMANN-LA ROCHE INC. 发明人 WALSER, ARMIN
分类号 C07D311/72;C07D405/06;C07D405/10;C07D407/04;C07D409/06;C07D409/14;C07D413/06;C07D491/04;C07D491/048 主分类号 C07D311/72
代理机构 代理人
主权项
地址